Adjustable Continence Therapy for treating female stress urinary incontinence
Official title: A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency
Run by Uromedica · NCT04248283 · Data updated 2026-11-12
This study is testing a new treatment called Adjustable Continence Therapy to see if it can help women with stress urinary incontinence who haven't had success with other treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 22 Years and up |
| Sex | Women only |
| Enrollment | 167 (estimated) |
| Sponsor | Uromedica Industry-sponsored |
| Drugs / interventions | radiation |
| Locations | 8 sites (Denver, Colorado and 7 other locations) |
| Status | Recruiting |
| Started | January 26, 2021 |
| Main results expected | May 31, 2027 |
| Study ends | May 31, 2032 |
| Registry record updated | October 6, 2026 |
| Trial ID | NCT04248283 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 22 and older who have been diagnosed with stress urinary incontinence and have not found relief from previous treatments.
✕Probably not a fit
Patients who are pregnant, have uncontrolled diabetes, or are undergoing radiation therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the safety and effectiveness of Adjustable Continence Therapy (ACT) in women diagnosed with stress urinary incontinence due to primary Intrinsic Sphincter Deficiency. It is a prospective, single-arm, non-randomized, multicenter case-series trial that will assess the clinical improvement in patients who have not responded to previous treatments. Participants will undergo the ACT procedure and will be monitored for outcomes related to urinary incontinence. The study seeks to provide valuable data on the therapeutic benefits of this innovative approach.
Why it matters
Potential benefit: If successful, this therapy could significantly improve the quality of life for women suffering from stress urinary incontinence.
How similar studies have gone: Other studies have shown promising results with similar therapeutic approaches, indicating potential for success with this method.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Female at least 22 years old 2. Diagnosed with stress urinary incontinence with primary Intrinsic Sphincter Deficiency 3. Provocative pad weight of greater than 11.0 grams 4. Candidate for surgical intervention 5. Negative urinalysis 6. Normal cystourethroscopy 7. Failed at least 6 months of previous treatment(s) for stress urinary incontinence (e.g., exercise regimen, electrical stimulation, surgical procedures, etc). Note: patients may have failed prior anti-incontinence procedures for SUI (e.g., suspension, sling, or urethral bulking agent) 8. Willing and able to sign informed consent and comply with trial follow-up requirements Exclusion Criteria: 1. Pregnant or lactating 2. Life expectancy of less than 5 years 3. Has uncontrolled diabetes as evidenced by HbA1c over 6.5% and fasting plasma glucose over 130 mg/dL 4. Has auto-immune disease 5. Undergoing radiation therapy 6. Active urinary tract infection 7. Detrusor instability refractory to medication 8. Reduced bladder compliance as defined by a cystometrogram 9. Significant residual volume (greater than 100 ml) after voiding in which detrusor contraction is weak, when the bladder volume is greater than or equal to 250 ml 10. Has, had, or is suspected of having bladder cancer 11. History of bladder stones 12. Urethral stricture evidenced during cystourethroscopy 13. Has a neurogenic bladder that is atonic or has detrusor sphincter dyssynergia 14. Has a diathesis, hemophilia, or a bleeding disorder 15. Has a rectocele, cystocele, urethrocele, enterocele, or pelvic prolapse of grade 3 or higher 16. Had prior pelvic radiotherapy 17. Had a prior artificial urinary sphincter implanted 18. Has a neurogenic condition known to affect bladder/sphincter function
Where it's running
-
University of Colorado
Denver, Colorado, United States Recruiting -
Idaho Urologic Institute, PA
Meridian, Idaho, United States Recruiting -
CHI Health Research Center
Omaha, Nebraska, United States Recruiting -
Penn State University
Hershey, Pennsylvania, United States Recruiting -
Hôpital de la Conception - Marseille
Marseille, France Recruiting -
CHU de Nantes
Nantes, France Recruiting
Show 2 more locations
-
Pitié Salpêtrière University Hospital Paris
Paris, France Recruiting -
Saint Lukes Health System
Independence, Missouri, United States Active not recruiting
Study contacts
- Study coordinator: Lisa Draper
- Email: USLDR@COLOPLAST.COM
- Phone: 612-834-7494
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using TENS for pain relief during outpatient urethral bulking in women with stress urinary incontinence.
This study is testing if using a TENS machine can help reduce pain for women undergoing a specific procedure for stress urinary incontinence.
-
Urinary incontinence in older adults: how leakage and bladder residuals relate to frailty
This study tests whether the severity of urinary leakage and leftover urine after voiding are linked to frailty and other geriatric outcomes in older adults visiting a urology clinic.
-
Compare two pelvic floor stimulation devices to see which helps with urinary incontinence in women
We’re testing if electromagnetic chair therapy can help women with mixed urinary incontinence as well as standard electrostimulation with biofeedback.
-
Educational video before urodynamic testing to see if it lowers anxiety
This study tests whether watching a short educational video before urodynamics helps reduce anxiety for women undergoing the test.
-
Improving Uroflowmetry: Do Pre-Procedure Reminders Help Women Undergoing Urodynamics
This study tests whether sending reminder calls before a urodynamics test helps women with pelvic floor disorders feel more prepared and less anxious, and whether it makes the procedure go more smoothly.
-
Rehabilitation and Sex Therapy to Improve Recovery After Prostate Cancer Treatment
This study tests whether adding telehealth sex therapy to pelvic floor physical therapy helps men recover sexual function after prostate cancer treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.